首页 > 最新文献

Clinical ophthalmology (Auckland, N.Z.)最新文献

英文 中文
Translation, Evaluation and Validation of the Adult Strabismus -20 (AS-20) Questionnaire in Swedish. 瑞典语成人斜视-20 (AS-20)问卷的翻译、评估与验证。
Pub Date : 2024-12-07 eCollection Date: 2024-01-01 DOI: 10.2147/OPTH.S477032
Lena Havstam Johansson, Anna Levinsson, Sara M Flodin

Purpose: To translate and validate the Adult Strabismus 20 (AS-20) questionnaire, a health-related quality of life questionnaire specifically devised for patients with strabismus.

Methods: The AS-20 was translated in accordance with the principles of good practice for the translation and cultural adaptation process for patient-related outcomes (PRO) according to the methodology recommended by the International Society for Pharmacoeconomics and Outcome Research (ISPOR). The translation, evaluation, and validation were performed in several steps. The study used both qualitative and quantitative methods and engaged 31 final-year orthoptic students in workshops, as well as 19 experts (experienced clinical orthoptists), 17 laymen (members of the public), and 17 patients from national eye clinics. The final translated questionnaire was tested for reliability and validity in 68 adults with strabismus by internal consistency using Cronbach´s alpha and content and construct validity using the Rasch analysis.

Results: The Swedish AS-20 showed a high level of internal consistency. Cronbach´s alpha was 0.95 for the psychosocial subscale and 0.92 for the functional subscale. However, the Rasch analysis indicated that both items and responses should be condensed to achieve content and construct validity.

Conclusion: The thorough translation and evaluation process resulted in a validated AS-20 questionnaire for use in the Swedish language, and shows reliability as an instrument to measure health-related quality of life (HRQoL) in adults with strabismus in a clinical setting.

目的:翻译并验证成人斜视20 (AS-20)问卷,这是一份专门为斜视患者设计的与健康相关的生活质量问卷。方法:按照患者相关结果(PRO)翻译和文化适应过程的良好实践原则,按照国际药物经济学与结果研究学会(ISPOR)推荐的方法对AS-20进行翻译。翻译、评估和验证分几个步骤进行。本研究采用定性和定量相结合的方法,研究对象包括31名参加研修班的大四学生、19名专家(经验丰富的临床眼科医生)、17名外行(公众)和17名来自国家眼科诊所的患者。采用Cronbach’s alpha和content对68名斜视成人的最终翻译问卷进行了信度和效度的内部一致性检验,并采用Rasch分析进行了结构效度检验。结果:瑞典AS-20量表具有较高的内部一致性。心理社会分量表的Cronbach’s alpha为0.95,功能分量表的Cronbach’s alpha为0.92。然而,Rasch分析表明,项目和回答都应该精简,以达到内容效度和结构效度。结论:经过全面的翻译和评估,得出了一份经过验证的瑞典语as -20问卷,并显示了作为临床环境中衡量成人斜视患者健康相关生活质量(HRQoL)工具的可靠性。
{"title":"Translation, Evaluation and Validation of the Adult Strabismus -20 (AS-20) Questionnaire in Swedish.","authors":"Lena Havstam Johansson, Anna Levinsson, Sara M Flodin","doi":"10.2147/OPTH.S477032","DOIUrl":"10.2147/OPTH.S477032","url":null,"abstract":"<p><strong>Purpose: </strong>To translate and validate the Adult Strabismus 20 (AS-20) questionnaire, a health-related quality of life questionnaire specifically devised for patients with strabismus.</p><p><strong>Methods: </strong>The AS-20 was translated in accordance with the principles of good practice for the translation and cultural adaptation process for patient-related outcomes (PRO) according to the methodology recommended by the International Society for Pharmacoeconomics and Outcome Research (ISPOR). The translation, evaluation, and validation were performed in several steps. The study used both qualitative and quantitative methods and engaged 31 final-year orthoptic students in workshops, as well as 19 experts (experienced clinical orthoptists), 17 laymen (members of the public), and 17 patients from national eye clinics. The final translated questionnaire was tested for reliability and validity in 68 adults with strabismus by internal consistency using Cronbach´s alpha and content and construct validity using the Rasch analysis.</p><p><strong>Results: </strong>The Swedish AS-20 showed a high level of internal consistency. Cronbach´s alpha was 0.95 for the psychosocial subscale and 0.92 for the functional subscale. However, the Rasch analysis indicated that both items and responses should be condensed to achieve content and construct validity.</p><p><strong>Conclusion: </strong>The thorough translation and evaluation process resulted in a validated AS-20 questionnaire for use in the Swedish language, and shows reliability as an instrument to measure health-related quality of life (HRQoL) in adults with strabismus in a clinical setting.</p>","PeriodicalId":93945,"journal":{"name":"Clinical ophthalmology (Auckland, N.Z.)","volume":"18 ","pages":"3615-3625"},"PeriodicalIF":0.0,"publicationDate":"2024-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11633298/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142815324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Characteristics and Prognostic Factors of Patients with Intraocular Foreign Bodies from a Tertiary Eye Center in North China. 华北某三级眼科中心眼内异物的临床特点及预后因素分析。
Pub Date : 2024-12-07 eCollection Date: 2024-01-01 DOI: 10.2147/OPTH.S492986
Xiaoli Xing, Fang Liu, Yan Qi, Jun Li, Bin Yu, Lei Wan

Background: This study aims to describe the epidemiology and clinical features of patients with intraocular foreign bodies (IOFBs) and analyze the prognostic factors influencing final vision.

Methods: We retrospectively reviewed medical records of patients with IOFBs admitted to Qingdao Eye Hospital of Shandong First Medical University between January 1, 2014, and December 31, 2021. Inclusion criteria involved complete clinical data details of patients diagnosed with intraocular foreign bodies in our hospital who were treated with concurrent surgery and based on IOFB position and characteristics, different surgical methods were employed. The minimum follow-up duration was 6 months. Exclusion criteria were foreign bodies retained in the orbit, organ failure, surgical contraindications, coagulation abnormalities, autoimmune diseases, history of ocular surgery, and ocular space-occupying lesions. Based on IOFB position and characteristics, different surgical methods were employed. Multivariate logistic regression analysis was performed to predict independent factors influencing final visual acuity after IOFBs.

Results: This study analyzed 159 patients (159 eyes) with IOFBs. Based on discharge and follow-up results, IOFB removal was performed through pars plana incision in 105 (67.9%) eyes, corneoscleral limbus incision in 24 (15.1%) eyes, and original wound in 27 (17.0%) eyes. Of these, 44 eyes underwent IOFB removal without vitrectomy, while 55 (34.6%) eyes were treated with silicone oil. Post-vitrectomy, three cases showed secondary macular membrane, five cases exhibited retinal detachment, and enucleation was necessary in three cases. The final best corrected visual acuity (BCVA, logMAR) was 1.06 ±0.88, significantly better than preoperative visual acuity of 1.65 ±0.87 (t = 8.21, p < 0.01). Multi-factor logistic regression analysis revealed that the length of corneal/scleral wound (OR=0.6 P < 0.05), maximum size of IOFB (OR=0.585 P < 0.05), initial presenting VA (OR=0.900 P < 0.05), and macular lesions(OR=0.400 P < 0.05) were risk factors for postoperative vision prognosis after intraocular foreign body surgery.

Conclusion: In a tertiary eye center in northern China, IOFBs predominantly affected the working-age group, particularly males. Factors such as wound length, IOFB size, initial presenting VA, and macular lesions might impact the final visual outcome.

背景:本研究旨在描述眼内异物(IOFBs)患者的流行病学和临床特征,并分析影响最终视力的预后因素。方法:回顾性分析2014年1月1日至2021年12月31日山东第一医科大学青岛眼科医院收治的IOFBs患者的病历。纳入标准包括我院诊断为眼内异物且同时行手术治疗的患者完整的临床资料细节,并根据IOFB的位置和特点,采用不同的手术方法。最小随访时间为6个月。排除标准为眼眶异物、器官衰竭、手术禁忌症、凝血异常、自身免疫性疾病、眼部手术史和眼部占位性病变。根据IOFB的位置和特点,采用不同的手术方法。采用多因素logistic回归分析预测影响IOFBs术后最终视力的独立因素。结果:本研究分析了159例(159眼)iofb患者。根据出院及随访结果,经平面部切口105例(67.9%),角膜巩膜缘切口24例(15.1%),原创处27例(17.0%)。其中,44只眼不切除玻璃体而摘除IOFB, 55只眼(34.6%)使用硅油。玻璃体切除术后,3例出现继发性黄斑膜,5例出现视网膜脱离,3例需要摘除视网膜核。最终最佳矫正视力(BCVA, logMAR)为1.06±0.88,明显优于术前的1.65±0.87 (t = 8.21, p < 0.01)。多因素logistic回归分析显示,角膜/巩膜创面长度(OR=0.6 P < 0.05)、IOFB最大尺寸(OR=0.585 P < 0.05)、首发VA (OR=0.900 P < 0.05)、黄斑病变(OR=0.400 P < 0.05)是影响眼内异物术后视力预后的危险因素。结论:在中国北方某三级眼科中心,IOFBs主要影响工作年龄人群,尤其是男性。诸如伤口长度、IOFB大小、初始表现VA和黄斑病变等因素可能影响最终的视力结果。
{"title":"Clinical Characteristics and Prognostic Factors of Patients with Intraocular Foreign Bodies from a Tertiary Eye Center in North China.","authors":"Xiaoli Xing, Fang Liu, Yan Qi, Jun Li, Bin Yu, Lei Wan","doi":"10.2147/OPTH.S492986","DOIUrl":"10.2147/OPTH.S492986","url":null,"abstract":"<p><strong>Background: </strong>This study aims to describe the epidemiology and clinical features of patients with intraocular foreign bodies (IOFBs) and analyze the prognostic factors influencing final vision.</p><p><strong>Methods: </strong>We retrospectively reviewed medical records of patients with IOFBs admitted to Qingdao Eye Hospital of Shandong First Medical University between January 1, 2014, and December 31, 2021. Inclusion criteria involved complete clinical data details of patients diagnosed with intraocular foreign bodies in our hospital who were treated with concurrent surgery and based on IOFB position and characteristics, different surgical methods were employed. The minimum follow-up duration was 6 months. Exclusion criteria were foreign bodies retained in the orbit, organ failure, surgical contraindications, coagulation abnormalities, autoimmune diseases, history of ocular surgery, and ocular space-occupying lesions. Based on IOFB position and characteristics, different surgical methods were employed. Multivariate logistic regression analysis was performed to predict independent factors influencing final visual acuity after IOFBs.</p><p><strong>Results: </strong>This study analyzed 159 patients (159 eyes) with IOFBs. Based on discharge and follow-up results, IOFB removal was performed through pars plana incision in 105 (67.9%) eyes, corneoscleral limbus incision in 24 (15.1%) eyes, and original wound in 27 (17.0%) eyes. Of these, 44 eyes underwent IOFB removal without vitrectomy, while 55 (34.6%) eyes were treated with silicone oil. Post-vitrectomy, three cases showed secondary macular membrane, five cases exhibited retinal detachment, and enucleation was necessary in three cases. The final best corrected visual acuity (BCVA, logMAR) was 1.06 ±0.88, significantly better than preoperative visual acuity of 1.65 ±0.87 (t = 8.21, p < 0.01). Multi-factor logistic regression analysis revealed that the length of corneal/scleral wound (OR=0.6 P < 0.05), maximum size of IOFB (OR=0.585 P < 0.05), initial presenting VA (OR=0.900 P < 0.05), and macular lesions(OR=0.400 P < 0.05) were risk factors for postoperative vision prognosis after intraocular foreign body surgery.</p><p><strong>Conclusion: </strong>In a tertiary eye center in northern China, IOFBs predominantly affected the working-age group, particularly males. Factors such as wound length, IOFB size, initial presenting VA, and macular lesions might impact the final visual outcome.</p>","PeriodicalId":93945,"journal":{"name":"Clinical ophthalmology (Auckland, N.Z.)","volume":"18 ","pages":"3635-3643"},"PeriodicalIF":0.0,"publicationDate":"2024-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11633304/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142815318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bio-Interventional Cyclodialysis and Allograft Scleral Reinforcement for Uveoscleral Outflow Enhancement in Open-Angle Glaucoma Patients: One-Year Clinical Outcomes. 生物介入睫状体透析和同种异体巩膜强化治疗开角型青光眼患者的巩膜流出增强:一年临床结果。
Pub Date : 2024-12-06 eCollection Date: 2024-01-01 DOI: 10.2147/OPTH.S496631
Tsontcho Ianchulev, Robert N Weinreb, Ernesto A Calvo, James Lewis, Gautam Kamthan, Arsham Sheybani, Douglas J Rhee, Iqbal K Ahmed

Background: To evaluate the one-year safety and effectiveness of bio-interventional cyclodialysis and scleral reinforcement in open-angle glaucoma (OAG) patients undergoing cataract surgery.

Methods: An ab-interno approach was used to create a sectoral cyclodialysis in OAG patients who were prospectively followed in a consecutive case series. Subsequent visco-cycloplasty with scleral reinforcement using homologous minimally modified allograft scaffold was completed to maintain patency of the cyclodialysis reservoir and increase uveoscleral outflow. Outcomes were mean medicated IOP and mean number of IOP-lowering medications. Safety outcomes were adverse events (AEs) and best-corrected visual acuity (BCVA) changes.

Results: Successful cyclodialysis and allograft bio-scaffold reinforcement was achieved in 117 eyes. There was minimal intraoperatie bleeding and few post-operative adverse events. At baseline, mean BCVA was 0.48 (95% CI: 0.42‒0.54; 20/40 Snellen) and mean ± SD medicated IOP was 20.2 ± 6.0 mmHg on 1.4 ± 1.3 IOP-lowering medications. At 12 months, there was a 27.1% reduction from baseline mean medicated IOP. In eyes with medicated baseline IOP > 21 mmHg (n = 45), there was a 39.7% paired IOP reduction at 12 months with a concurrent reduction in the mean number of IOP lowering medications to 0.8 ± 0.9 which were statistically significant (p < 0.01). For all eyes, 81.9% achieved a medicated IOP ≤ 18 mmHg with no increase in medications at 12 months. To achieve target IOP control, secondary glaucoma surgery was performed in 3.2% of the cases.

Conclusion: IOP lowering through uveoscleral outflow enhancement can be achieved by means of a bio-interventional cyclodialysis procedure with allograft scleral reinforcement.

背景:评价开角型青光眼(OAG)白内障手术患者生物介入睫状体透析和巩膜加固治疗一年的安全性和有效性。方法:采用ab-interno方法对连续病例系列前瞻性随访的OAG患者进行部门性循环透析。随后使用同源最小修饰同种异体支架进行巩膜加固的黏液环成形术,以维持环透析库的通畅并增加巩膜流出。结果是平均药物IOP和平均降低IOP药物的数量。安全性结果为不良事件(ae)和最佳矫正视力(BCVA)变化。结果:117眼睫状体透析及同种异体生物支架加固成功。术中出血少,术后不良事件少。基线时,平均BCVA为0.48 (95% CI: 0.42-0.54;20/40 Snellen),使用1.4±1.3种降眼压药物时,平均±SD眼压为20.2±6.0 mmHg。12个月时,平均服药IOP较基线降低27.1%。在基线IOP为21 mmHg (n = 45)的眼睛中,12个月时配对IOP降低39.7%,同时降低IOP的平均药物数量减少到0.8±0.9,具有统计学意义(p < 0.01)。在所有眼睛中,81.9%的患者在12个月时实现了药物IOP≤18 mmHg,且药物没有增加。3.2%的患者接受了继发性青光眼手术。结论:异体巩膜加固生物介入睫状体透析术可通过增强巩膜流出来降低眼压。
{"title":"Bio-Interventional Cyclodialysis and Allograft Scleral Reinforcement for Uveoscleral Outflow Enhancement in Open-Angle Glaucoma Patients: One-Year Clinical Outcomes.","authors":"Tsontcho Ianchulev, Robert N Weinreb, Ernesto A Calvo, James Lewis, Gautam Kamthan, Arsham Sheybani, Douglas J Rhee, Iqbal K Ahmed","doi":"10.2147/OPTH.S496631","DOIUrl":"10.2147/OPTH.S496631","url":null,"abstract":"<p><strong>Background: </strong>To evaluate the one-year safety and effectiveness of bio-interventional cyclodialysis and scleral reinforcement in open-angle glaucoma (OAG) patients undergoing cataract surgery.</p><p><strong>Methods: </strong>An ab-interno approach was used to create a sectoral cyclodialysis in OAG patients who were prospectively followed in a consecutive case series. Subsequent visco-cycloplasty with scleral reinforcement using homologous minimally modified allograft scaffold was completed to maintain patency of the cyclodialysis reservoir and increase uveoscleral outflow. Outcomes were mean medicated IOP and mean number of IOP-lowering medications. Safety outcomes were adverse events (AEs) and best-corrected visual acuity (BCVA) changes.</p><p><strong>Results: </strong>Successful cyclodialysis and allograft bio-scaffold reinforcement was achieved in 117 eyes. There was minimal intraoperatie bleeding and few post-operative adverse events. At baseline, mean BCVA was 0.48 (95% CI: 0.42‒0.54; 20/40 Snellen) and mean ± SD medicated IOP was 20.2 ± 6.0 mmHg on 1.4 ± 1.3 IOP-lowering medications. At 12 months, there was a 27.1% reduction from baseline mean medicated IOP. In eyes with medicated baseline IOP > 21 mmHg (n = 45), there was a 39.7% paired IOP reduction at 12 months with a concurrent reduction in the mean number of IOP lowering medications to 0.8 ± 0.9 which were statistically significant (p < 0.01). For all eyes, 81.9% achieved a medicated IOP ≤ 18 mmHg with no increase in medications at 12 months. To achieve target IOP control, secondary glaucoma surgery was performed in 3.2% of the cases.</p><p><strong>Conclusion: </strong>IOP lowering through uveoscleral outflow enhancement can be achieved by means of a bio-interventional cyclodialysis procedure with allograft scleral reinforcement.</p>","PeriodicalId":93945,"journal":{"name":"Clinical ophthalmology (Auckland, N.Z.)","volume":"18 ","pages":"3605-3614"},"PeriodicalIF":0.0,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11629670/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142808843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The THINK Study: Testing Hypoesthesia and the Incidence of Neurotrophic Keratopathy in Cataract Patients with Dry Eye. THINK研究:检测干眼白内障患者的感觉减退和神经营养性角膜病变的发生率。
Pub Date : 2024-12-06 eCollection Date: 2024-01-01 DOI: 10.2147/OPTH.S501452
John A Hovanesian

Purpose: This study was designed to determine the frequency of neurotrophic keratopathy (NK) among patients presenting for cataract surgery consultation in a suburban US practice.

Methods: Patients presenting for cataract consultation were evaluated with corneal staining without anesthetic. Those with grade 1 or greater corneal stain and a tear breakup time (TBUT) of ≤10 underwent corneal sensitivity testing with a Cochet Bonnet esthesiometer. The study also evaluated patient SPEED score symptoms, corrected distance visual acuity (CDVA), corneal higher-order aberrations (HOAs), and conjunctival hyperemia.

Results: Among the 31 patients enrolled, mean corneal esthesiometry was 40 ± 9.5 mm (range 13 to 55). Esthesiometry of ≤40 mm, indicating neurotrophic keratopathy, was detected in 18 (58%, 95% CI 39-75%) patients. Corneal higher-order aberrations were significantly worse at 0.83 ± 0.22 µ in the group with NK vs 0.67 ± 0.16 among patients without NK (P < 0.028). A nonsignificant correlation was found between reduced corneal sensitivity and reduced symptoms. Older patients had slightly reduced sensation, but this trend was not statistically significant. No trend was seen between reduced sensation and either CDVA or corneal staining.

Conclusion: More than half of patients presenting for cataract evaluation with dry eye had stage 1 neurotrophic keratopathy. These patients had significantly worse higher-order aberrations than patients with normal sensitivity. Among patients with NK, symptoms were milder and age was higher, but neither trend was statistically significant. No trend was observed between corneal sensation and either corneal staining or CDVA.

目的:本研究旨在确定美国郊区白内障手术会诊患者中神经营养性角膜病变(NK)的频率。方法:对前来就诊的白内障患者进行无麻醉角膜染色评价。1级及以上角膜染色且TBUT≤10的患者使用Cochet Bonnet角膜感受器进行角膜敏感性测试。该研究还评估了患者的SPEED评分症状、矫正距离视力(CDVA)、角膜高阶像差(HOAs)和结膜充血。结果:在31例入组患者中,平均角膜感觉测量值为40±9.5 mm(范围13 ~ 55)。18例(58%,95% CI 39-75%)患者的感觉测量值≤40 mm,表明神经营养性角膜病变。NK组角膜高阶像差为0.83±0.22µ,NK组为0.67±0.16µ,差异有统计学意义(P < 0.028)。角膜敏感性降低与症状减轻之间无显著相关性。老年患者有轻微的感觉下降,但这种趋势在统计学上不显著。感觉减退与CDVA或角膜染色之间没有明显的联系。结论:超过一半的干眼白内障患者为1期神经营养性角膜病变。这些患者的高阶畸变明显比正常敏感性患者更严重。NK患者症状较轻,年龄较高,但两种趋势均无统计学意义。角膜感觉与角膜染色或CDVA之间均无明显变化。
{"title":"The THINK Study: Testing Hypoesthesia and the Incidence of Neurotrophic Keratopathy in Cataract Patients with Dry Eye.","authors":"John A Hovanesian","doi":"10.2147/OPTH.S501452","DOIUrl":"10.2147/OPTH.S501452","url":null,"abstract":"<p><strong>Purpose: </strong>This study was designed to determine the frequency of neurotrophic keratopathy (NK) among patients presenting for cataract surgery consultation in a suburban US practice.</p><p><strong>Methods: </strong>Patients presenting for cataract consultation were evaluated with corneal staining without anesthetic. Those with grade 1 or greater corneal stain and a tear breakup time (TBUT) of ≤10 underwent corneal sensitivity testing with a Cochet Bonnet esthesiometer. The study also evaluated patient SPEED score symptoms, corrected distance visual acuity (CDVA), corneal higher-order aberrations (HOAs), and conjunctival hyperemia.</p><p><strong>Results: </strong>Among the 31 patients enrolled, mean corneal esthesiometry was 40 ± 9.5 mm (range 13 to 55). Esthesiometry of ≤40 mm, indicating neurotrophic keratopathy, was detected in 18 (58%, 95% CI 39-75%) patients. Corneal higher-order aberrations were significantly worse at 0.83 ± 0.22 µ in the group with NK vs 0.67 ± 0.16 among patients without NK (P < 0.028). A nonsignificant correlation was found between reduced corneal sensitivity and reduced symptoms. Older patients had slightly reduced sensation, but this trend was not statistically significant. No trend was seen between reduced sensation and either CDVA or corneal staining.</p><p><strong>Conclusion: </strong>More than half of patients presenting for cataract evaluation with dry eye had stage 1 neurotrophic keratopathy. These patients had significantly worse higher-order aberrations than patients with normal sensitivity. Among patients with NK, symptoms were milder and age was higher, but neither trend was statistically significant. No trend was observed between corneal sensation and either corneal staining or CDVA.</p>","PeriodicalId":93945,"journal":{"name":"Clinical ophthalmology (Auckland, N.Z.)","volume":"18 ","pages":"3627-3633"},"PeriodicalIF":0.0,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11630729/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142808863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Demographic Modifiers on Readability of Myopia Education Materials Generated by Large Language Models. 大语言模型生成的近视教育材料中人口统计学修饰符对可读性的影响。
Pub Date : 2024-12-04 eCollection Date: 2024-01-01 DOI: 10.2147/OPTH.S483024
Gabriela G Lee, Deniz Goodman, Ta Chen Peter Chang

Background: The rise of large language models (LLM) promises to widely impact healthcare providers and patients alike. As these tools reflect the biases of currently available data on the internet, there is a risk that increasing LLM use will proliferate these biases and affect information quality. This study aims to characterize the effects of different race, ethnicity, and gender modifiers in question prompts presented to three large language models (LLM) on the length and readability of patient education materials about myopia.

Methods: ChatGPT, Gemini, and Copilot were provided a standardized prompt incorporating demographic modifiers to inquire about myopia. The races and ethnicities evaluated were Asian, Black, Hispanic, Native American, and White. Gender was limited to male or female. The prompt was inserted five times into new chat windows. Responses were analyzed for readability by word count, Simple Measure of Gobbledygook (SMOG) index, Flesch-Kincaid Grade Level, and Flesch Reading Ease score. Significant differences were analyzed using two-way ANOVA on SPSS.

Results: A total of 150 responses were analyzed. There were no differences in SMOG index, Flesch-Kincaid Grade Level, or Flesch Reading Ease scores between responses generated with prompts containing different gender, race, or ethnicity modifiers using ChatGPT or Copilot. Gemini-generated responses differed significantly in their SMOG Index, Flesch-Kincaid Grade Level, and Flesch Reading Ease based on the race mentioned in the prompt (p<0.05).

Conclusion: Patient demographic information impacts the reading level of educational material generated by Gemini but not by ChatGPT or Copilot. As patients use LLMs to understand ophthalmologic diagnoses like myopia, clinicians and users should be aware of demographic influences on readability. Patient gender, race, and ethnicity may be overlooked variables affecting the readability of LLM-generated education materials, which can impact patient care. Future research could focus on the accuracy of generated information to identify potential risks of misinformation.

背景:大型语言模型(LLM)的兴起有望广泛影响医疗保健提供者和患者。由于这些工具反映了互联网上当前可用数据的偏差,因此法学硕士使用的增加可能会增加这些偏差并影响信息质量。本研究旨在探讨不同种族、民族和性别修饰语对三种大型语言模型(LLM)患者近视教育材料长度和可读性的影响。方法:对ChatGPT、Gemini和Copilot进行纳入人口统计学修饰词的标准化提示询问近视情况。被评估的种族和民族包括亚洲人、黑人、西班牙人、美洲原住民和白人。性别仅限于男性或女性。在新的聊天窗口中插入了五次提示符。通过字数统计、简单测量的Gobbledygook (SMOG)指数、Flesch- kincaid等级水平和Flesch阅读易用性评分来分析回复的可读性。采用SPSS的双向方差分析分析显著差异。结果:共分析了150份问卷。在使用ChatGPT或Copilot使用包含不同性别、种族或民族修饰符的提示生成的回答之间,烟雾指数、Flesch- kinaid Grade Level或Flesch Reading Ease得分没有差异。根据提示中提到的种族,双子座生成的回答在SMOG指数、Flesch- kincaid Grade Level和Flesch Reading Ease方面存在显著差异(pConclusion:患者人口统计信息影响双子座生成的教育材料的阅读水平,而ChatGPT或Copilot生成的教育材料没有影响。)当患者使用llm来理解近视等眼科诊断时,临床医生和用户应该意识到人口统计学对可读性的影响。患者的性别、种族和民族可能被忽视的变量影响法学硕士生成的教育材料的可读性,这可能会影响患者的护理。未来的研究可以关注生成信息的准确性,以识别错误信息的潜在风险。
{"title":"Impact of Demographic Modifiers on Readability of Myopia Education Materials Generated by Large Language Models.","authors":"Gabriela G Lee, Deniz Goodman, Ta Chen Peter Chang","doi":"10.2147/OPTH.S483024","DOIUrl":"10.2147/OPTH.S483024","url":null,"abstract":"<p><strong>Background: </strong>The rise of large language models (LLM) promises to widely impact healthcare providers and patients alike. As these tools reflect the biases of currently available data on the internet, there is a risk that increasing LLM use will proliferate these biases and affect information quality. This study aims to characterize the effects of different race, ethnicity, and gender modifiers in question prompts presented to three large language models (LLM) on the length and readability of patient education materials about myopia.</p><p><strong>Methods: </strong>ChatGPT, Gemini, and Copilot were provided a standardized prompt incorporating demographic modifiers to inquire about myopia. The races and ethnicities evaluated were Asian, Black, Hispanic, Native American, and White. Gender was limited to male or female. The prompt was inserted five times into new chat windows. Responses were analyzed for readability by word count, Simple Measure of Gobbledygook (SMOG) index, Flesch-Kincaid Grade Level, and Flesch Reading Ease score. Significant differences were analyzed using two-way ANOVA on SPSS.</p><p><strong>Results: </strong>A total of 150 responses were analyzed. There were no differences in SMOG index, Flesch-Kincaid Grade Level, or Flesch Reading Ease scores between responses generated with prompts containing different gender, race, or ethnicity modifiers using ChatGPT or Copilot. Gemini-generated responses differed significantly in their SMOG Index, Flesch-Kincaid Grade Level, and Flesch Reading Ease based on the race mentioned in the prompt (p<0.05).</p><p><strong>Conclusion: </strong>Patient demographic information impacts the reading level of educational material generated by Gemini but not by ChatGPT or Copilot. As patients use LLMs to understand ophthalmologic diagnoses like myopia, clinicians and users should be aware of demographic influences on readability. Patient gender, race, and ethnicity may be overlooked variables affecting the readability of LLM-generated education materials, which can impact patient care. Future research could focus on the accuracy of generated information to identify potential risks of misinformation.</p>","PeriodicalId":93945,"journal":{"name":"Clinical ophthalmology (Auckland, N.Z.)","volume":"18 ","pages":"3591-3604"},"PeriodicalIF":0.0,"publicationDate":"2024-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11625417/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142803690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ahmed Glaucoma Valve Implantation in Jordan: Indications and Complications. 约旦Ahmed青光眼瓣膜植入术:适应症和并发症。
Pub Date : 2024-12-04 eCollection Date: 2024-01-01 DOI: 10.2147/OPTH.S496586
Asem A Alqudah, Ahmed G Obaidi, Mohammad Al Zoubi, Abdelwahab Aleshawi

Aim: The main indications for Ahmed glaucoma valve (AGV) include neovascular glaucoma, congenital glaucoma, primary open angle glaucoma and patients with failed previous trabeculectomy. This article aims to investigate the complications of AGV in Jordanian glaucoma patients and to justify the main risk factors.

Methods: Retrospectively, we report 87 eyes of 83 patients who underwent AGV implantation for different indications. The database included demographic data, past ocular and medical history, the indication for surgery, the perioperative outcome parameters at different follow-up visits, and the developed complications at each post-operative visit.

Results: More than half of the patients (54%) were males. The mean age of the patients was 47.4 years. Neovascular glaucoma was the most common indication for AGV implantation. Valve encapsulation was the most encountered complication. About one quarter of the eyes at one time underwent valve revision. Younger patients, neovascular glaucoma and congenital glaucoma were associated significantly with AGV failure and for the need for revision surgery.

Conclusion: AGV is the predominant glaucoma surgery performed in Jordan. Valve encapsulation is the most common complication for AGV implant in Jordanian patients which may be related to racial and genetic factors. Neovascular glaucoma has a high burden in Jordan and secondary causes should be controlled adequately.

目的:Ahmed青光眼瓣膜(AGV)的主要适应症包括新生血管性青光眼、先天性青光眼、原发性开角型青光眼和既往小梁切除术失败的患者。本文旨在探讨AGV在约旦青光眼患者中的并发症,并证明其主要危险因素。方法:回顾性报道83例87眼不同适应症的AGV植入术。该数据库包括人口统计资料、既往眼科病史和病史、手术指征、不同随访的围手术期结局参数以及每次术后随访时发生的并发症。结果:半数以上(54%)患者为男性。患者平均年龄47.4岁。新血管性青光眼是AGV植入术最常见的适应症。瓣膜封装是最常见的并发症。大约四分之一的眼睛在同一时间进行了瓣膜修复。年轻患者、新生血管性青光眼和先天性青光眼与AGV失败和需要翻修手术显著相关。结论:AGV是约旦主要的青光眼手术。瓣膜包封是约旦患者最常见的AGV植入并发症,可能与种族和遗传因素有关。在约旦,新生血管性青光眼的负担很高,继发原因应得到充分控制。
{"title":"Ahmed Glaucoma Valve Implantation in Jordan: Indications and Complications.","authors":"Asem A Alqudah, Ahmed G Obaidi, Mohammad Al Zoubi, Abdelwahab Aleshawi","doi":"10.2147/OPTH.S496586","DOIUrl":"10.2147/OPTH.S496586","url":null,"abstract":"<p><strong>Aim: </strong>The main indications for Ahmed glaucoma valve (AGV) include neovascular glaucoma, congenital glaucoma, primary open angle glaucoma and patients with failed previous trabeculectomy. This article aims to investigate the complications of AGV in Jordanian glaucoma patients and to justify the main risk factors.</p><p><strong>Methods: </strong>Retrospectively, we report 87 eyes of 83 patients who underwent AGV implantation for different indications. The database included demographic data, past ocular and medical history, the indication for surgery, the perioperative outcome parameters at different follow-up visits, and the developed complications at each post-operative visit.</p><p><strong>Results: </strong>More than half of the patients (54%) were males. The mean age of the patients was 47.4 years. Neovascular glaucoma was the most common indication for AGV implantation. Valve encapsulation was the most encountered complication. About one quarter of the eyes at one time underwent valve revision. Younger patients, neovascular glaucoma and congenital glaucoma were associated significantly with AGV failure and for the need for revision surgery.</p><p><strong>Conclusion: </strong>AGV is the predominant glaucoma surgery performed in Jordan. Valve encapsulation is the most common complication for AGV implant in Jordanian patients which may be related to racial and genetic factors. Neovascular glaucoma has a high burden in Jordan and secondary causes should be controlled adequately.</p>","PeriodicalId":93945,"journal":{"name":"Clinical ophthalmology (Auckland, N.Z.)","volume":"18 ","pages":"3581-3590"},"PeriodicalIF":0.0,"publicationDate":"2024-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11625418/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142803092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhancing OCT Reliability: The Role of Eye-Tracking in Achieving Consistent Retinal Measurements [Response to Letter]. 增强OCT可靠性:眼动追踪在视网膜测量一致性中的作用[回复信件]。
Pub Date : 2024-12-03 eCollection Date: 2024-01-01 DOI: 10.2147/OPTH.S505608
Ge Yang, Salma Firdaus, Lívia Figueiredo Pereira, Yumin Huang-Link
{"title":"Enhancing OCT Reliability: The Role of Eye-Tracking in Achieving Consistent Retinal Measurements [Response to Letter].","authors":"Ge Yang, Salma Firdaus, Lívia Figueiredo Pereira, Yumin Huang-Link","doi":"10.2147/OPTH.S505608","DOIUrl":"10.2147/OPTH.S505608","url":null,"abstract":"","PeriodicalId":93945,"journal":{"name":"Clinical ophthalmology (Auckland, N.Z.)","volume":"18 ","pages":"3579-3580"},"PeriodicalIF":0.0,"publicationDate":"2024-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11624660/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142803184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and Safety of Ab-Interno Canaloplasty in Post-Keratoplasty Patients: 3-Year Results. Ab-Interno导管成形术在角膜移植术后患者中的疗效和安全性:3年的结果。
Pub Date : 2024-11-30 eCollection Date: 2024-01-01 DOI: 10.2147/OPTH.S487384
Liam D Redden, Kamran M Riaz, David A Murphy, Kai Ding, Mahmoud A Khaimi

Purpose: To evaluate the effectiveness and safety of ab-interno canaloplasty (ABiC) for managing intraocular pressure (IOP) in patients following keratoplasty over a three-year period.

Methods: This retrospective analysis focused on post-keratoplasty patients treated with ABiC with the iTrack microcatheter (Nova Eye Medical, Fremont, CA, USA) at a single institution. The study assessed the procedure's impact on IOP control, graft survival, and reliance on topical hypotensive medications, with additional observation for any postoperative complications. Surgical success criteria included the percentage of eyes with IOP ≤15 mmHg, IOP ≤18 mmHg, ≥20% IOP reduction, medication-free eyes, and eyes with concurrent IOP and medication reductions.

Results: ABiC was performed successfully in a cohort of 16 post-keratoplasty (7 penetrating keratoplasty and 9 endothelial keratoplasty (EK)) eyes. Preoperative mean IOP of 25.8±7.2 mmHg was significantly reduced to 13.4±2.9 mmHg (p<0.001) at 1 year postoperatively and maintained at 13.1±3.9 mmHg (p=0.009) at 3 years postoperatively. The mean number of glaucoma medications was 3.5±1.7 at baseline, 2.8±1.3 at 1 year (p=0.107), and 2.5±1.2 at 3 years postoperatively (p=0.088). Eight eyes (66.7%) maintained IOP ≤ 15 mmHg, and 10 eyes (83.3%) maintained ≥ 20% IOP reduction at 3 years. The mean IOP and medication reductions from baseline at 3 years were -49.2% and -28.6%, respectively. Graft clarity was preserved in all patients except for one case of late graft failure that necessitated a repeat EK procedure. Post-ABiC complications included transient hyphema in two patients, neither of which led to long-term adverse outcomes.

Conclusion: ABiC appears to be an effective and safe surgical intervention for sustained IOP reduction in post-keratoplasty patients. Graft survival trends are encouraging, and there was a low incidence of complications over a three-year follow-up period.

目的:评价ab-间管成形术(ABiC)在角膜移植术后3年内控制眼压(IOP)的有效性和安全性。方法:本回顾性分析集中在单一机构使用iTrack微导管(Nova Eye Medical, Fremont, CA, USA)进行角膜移植术后ABiC治疗的患者。该研究评估了手术对IOP控制、移植物存活和对局部降压药物的依赖的影响,并观察了任何术后并发症。手术成功标准包括IOP≤15mmhg、IOP≤18mmhg、IOP降低≥20%、无药物眼和同时IOP和药物降低的眼的百分比。结果:ABiC在16只角膜移植术后(7只穿透性角膜移植术和9只内皮性角膜移植术)成功进行。术前平均IOP由25.8±7.2 mmHg显著降低至13.4±2.9 mmHg。结论:ABiC是角膜移植术后患者持续降低IOP的有效且安全的手术干预。移植物存活的趋势是令人鼓舞的,在三年的随访期间,并发症的发生率很低。
{"title":"Efficacy and Safety of Ab-Interno Canaloplasty in Post-Keratoplasty Patients: 3-Year Results.","authors":"Liam D Redden, Kamran M Riaz, David A Murphy, Kai Ding, Mahmoud A Khaimi","doi":"10.2147/OPTH.S487384","DOIUrl":"10.2147/OPTH.S487384","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the effectiveness and safety of ab-interno canaloplasty (ABiC) for managing intraocular pressure (IOP) in patients following keratoplasty over a three-year period.</p><p><strong>Methods: </strong>This retrospective analysis focused on post-keratoplasty patients treated with ABiC with the iTrack microcatheter (Nova Eye Medical, Fremont, CA, USA) at a single institution. The study assessed the procedure's impact on IOP control, graft survival, and reliance on topical hypotensive medications, with additional observation for any postoperative complications. Surgical success criteria included the percentage of eyes with IOP ≤15 mmHg, IOP ≤18 mmHg, ≥20% IOP reduction, medication-free eyes, and eyes with concurrent IOP and medication reductions.</p><p><strong>Results: </strong>ABiC was performed successfully in a cohort of 16 post-keratoplasty (7 penetrating keratoplasty and 9 endothelial keratoplasty (EK)) eyes. Preoperative mean IOP of 25.8±7.2 mmHg was significantly reduced to 13.4±2.9 mmHg (p<0.001) at 1 year postoperatively and maintained at 13.1±3.9 mmHg (p=0.009) at 3 years postoperatively. The mean number of glaucoma medications was 3.5±1.7 at baseline, 2.8±1.3 at 1 year (p=0.107), and 2.5±1.2 at 3 years postoperatively (p=0.088). Eight eyes (66.7%) maintained IOP ≤ 15 mmHg, and 10 eyes (83.3%) maintained ≥ 20% IOP reduction at 3 years. The mean IOP and medication reductions from baseline at 3 years were -49.2% and -28.6%, respectively. Graft clarity was preserved in all patients except for one case of late graft failure that necessitated a repeat EK procedure. Post-ABiC complications included transient hyphema in two patients, neither of which led to long-term adverse outcomes.</p><p><strong>Conclusion: </strong>ABiC appears to be an effective and safe surgical intervention for sustained IOP reduction in post-keratoplasty patients. Graft survival trends are encouraging, and there was a low incidence of complications over a three-year follow-up period.</p>","PeriodicalId":93945,"journal":{"name":"Clinical ophthalmology (Auckland, N.Z.)","volume":"18 ","pages":"3567-3577"},"PeriodicalIF":0.0,"publicationDate":"2024-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11616415/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142782170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Visual and Refractive Outcomes of Keratorefractive Lenticule Extraction for Compound Myopic Astigmatism Between VisuMax and VISUMAX 800. VisuMax与VisuMax 800复合近视散光角膜屈光透镜提取术视力及屈光效果比较
Pub Date : 2024-11-30 eCollection Date: 2024-01-01 DOI: 10.2147/OPTH.S492552
Aadithreya Varman, Arulmozhi Varman, Dinesh Balakumar

Purpose: To evaluate the visual outcomes of keratorefractive lenticule extraction using a new version of a femtosecond laser platform with semi-automated cyclotorsion compensation in comparison to the previous generation without cyclotorsion control.

Methods: This was an ambispective study of consecutive eyes treated by SMILE with the VisuMax and VISUMAX 800 femtosecond lasers at the Uma Eye clinic, Chennai, India between June 2022 and July 2023. Inclusion criteria were myopia up to -10 D and astigmatism between 1.5 D and 5 D. Data was retrospectively collected from patients that underwent SMILE using the VisuMax without cyclotorsion compensation and prospectively collected from patients undergoing SMILE using the VISUMAX 800 with Oculign and Centralign software aids.

Results: Data was collected from a total of 220 eyes that underwent routine SMILE; 115 eyes with VisuMax (VM500 group) and 105 eyes with VISUMAX 800 (VM800 group). The mean attempted spherical equivalent was -4.82±2.16 D in the VM500 group and -4.80±2.24 in the VM800 group. At the 3-month postoperative visit, 94% of eyes in the VM500 group and 98% of eyes in the VM800 group had an UDVA of 20/20 or better. Accuracy of the SEQ showed that 71% of eyes were within ±0.50 D and 100% were within ±1.00 D of target in the VM500 group and 96% of eyes were within ±0.50 D and 100% were within ±1.00 D of target in the VM800 group. There were no reported cases of suction loss or any other intraoperative complication in either group.

Conclusion: SMILE with the VisuMax and VISUMAX 800 provided excellent visual and refractive outcomes for subjects with myopic astigmatism. The VISUMAX 800, using Oculign and Centralign aids, demonstrated better accuracy when correcting cylinder greater than 2 D compared to the VisuMax without using manual cyclotorsion compensation.

目的:评价使用新型飞秒激光平台进行角膜屈光性晶状体提取的视觉效果,该平台具有半自动旋扭补偿功能,并与上一代无旋扭控制的飞秒激光平台进行比较。方法:对2022年6月至2023年7月在印度金奈乌玛眼科诊所使用VisuMax和VisuMax 800飞秒激光器进行SMILE治疗的连续眼睛进行双视角研究。纳入标准为近视至-10 D,散光在1.5 D至5 D之间。数据回顾性收集使用无旋回补偿VisuMax进行SMILE的患者,前瞻性收集使用VisuMax 800配合Oculign和Centralign软件辅助进行SMILE的患者。结果:共收集220只常规SMILE眼的数据;115只眼睛使用VisuMax (VM500组),105只眼睛使用VisuMax 800 (VM800组)。VM500组和VM800组的平均尝试球形当量分别为-4.82±2.16 D和-4.80±2.24 D。术后3个月随访时,VM500组94%的眼睛和VM800组98%的眼睛UDVA为20/20或更好。VM500组有71%的眼睛在目标的±0.50 D范围内,100%在目标的±1.00 D范围内;VM800组有96%的眼睛在目标的±0.50 D范围内,100%在目标的±1.00 D范围内。两组均未出现吸力丢失或其他术中并发症。结论:SMILE配用VisuMax和VisuMax 800对近视散光患者有良好的视力和屈光效果。使用Oculign和Centralign辅助工具的VISUMAX 800在校正大于2维的圆柱体时,与不使用手动回旋扭转补偿的VISUMAX相比,显示出更好的精度。
{"title":"Comparison of Visual and Refractive Outcomes of Keratorefractive Lenticule Extraction for Compound Myopic Astigmatism Between VisuMax and VISUMAX 800.","authors":"Aadithreya Varman, Arulmozhi Varman, Dinesh Balakumar","doi":"10.2147/OPTH.S492552","DOIUrl":"10.2147/OPTH.S492552","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the visual outcomes of keratorefractive lenticule extraction using a new version of a femtosecond laser platform with semi-automated cyclotorsion compensation in comparison to the previous generation without cyclotorsion control.</p><p><strong>Methods: </strong>This was an ambispective study of consecutive eyes treated by SMILE with the VisuMax and VISUMAX 800 femtosecond lasers at the Uma Eye clinic, Chennai, India between June 2022 and July 2023. Inclusion criteria were myopia up to -10 D and astigmatism between 1.5 D and 5 D. Data was retrospectively collected from patients that underwent SMILE using the VisuMax without cyclotorsion compensation and prospectively collected from patients undergoing SMILE using the VISUMAX 800 with Oculign and Centralign software aids.</p><p><strong>Results: </strong>Data was collected from a total of 220 eyes that underwent routine SMILE; 115 eyes with VisuMax (VM500 group) and 105 eyes with VISUMAX 800 (VM800 group). The mean attempted spherical equivalent was -4.82±2.16 D in the VM500 group and -4.80±2.24 in the VM800 group. At the 3-month postoperative visit, 94% of eyes in the VM500 group and 98% of eyes in the VM800 group had an UDVA of 20/20 or better. Accuracy of the SEQ showed that 71% of eyes were within ±0.50 D and 100% were within ±1.00 D of target in the VM500 group and 96% of eyes were within ±0.50 D and 100% were within ±1.00 D of target in the VM800 group. There were no reported cases of suction loss or any other intraoperative complication in either group.</p><p><strong>Conclusion: </strong>SMILE with the VisuMax and VISUMAX 800 provided excellent visual and refractive outcomes for subjects with myopic astigmatism. The VISUMAX 800, using Oculign and Centralign aids, demonstrated better accuracy when correcting cylinder greater than 2 D compared to the VisuMax without using manual cyclotorsion compensation.</p>","PeriodicalId":93945,"journal":{"name":"Clinical ophthalmology (Auckland, N.Z.)","volume":"18 ","pages":"3557-3566"},"PeriodicalIF":0.0,"publicationDate":"2024-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11616419/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142782169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adverse Ocular Impact and Emerging Therapeutic Potential of Cannabis and Cannabinoids: A Narrative Review. 大麻和大麻素对眼睛的不良影响和新出现的治疗潜力:叙述回顾。
Pub Date : 2024-11-29 eCollection Date: 2024-01-01 DOI: 10.2147/OPTH.S501494
Mostafa Bondok, Anne Xuan-Lan Nguyen, Leonardo Lando, Albert Y Wu

Cannabis is the most used drug worldwide with an estimated 219 million users. This narrative review aims to explore the adverse effects and therapeutic applications of cannabis and cannabinoids on the eye, given its growing clinical and non-clinical uses. The current literature reports several adverse ocular effects of cannabis and cannabinoids, including eyelid tremor, ptosis, reduced corneal endothelial cell density, dry eyes, red eyes, and neuro-retinal dysfunction. Cannabinoids may transiently impair night vision, depth perception, binocular and monocular contrast sensitivity, and dynamic visual acuity. Cannabinoids are not currently considered a first-line treatment option for any ocular conditions. Δ-9-tetrahydrocannabinol been shown to result in short-term intraocular pressure reduction, but insufficient evidence to support its use in treating glaucoma exists. Potential therapeutic applications of cannabinoids include their use as a second-line agent for treatment-refractory blepharospasm, for dry eye disease given corneal anti-inflammatory properties, and for suppression of pendular nystagmus in individuals with multiple sclerosis, which all necessitate further research for informed clinical practices.

大麻是世界上使用最多的毒品,估计有2.19亿使用者。鉴于大麻和大麻素的临床和非临床用途日益增加,本综述旨在探讨大麻和大麻素对眼睛的不良影响和治疗应用。目前的文献报道了大麻和大麻素对眼部的几种不良影响,包括眼睑震颤、上睑下垂、角膜内皮细胞密度降低、眼睛干涩、眼睛发红和神经视网膜功能障碍。大麻素可能会暂时损害夜视、深度知觉、双眼和单眼对比敏感度以及动态视力。大麻素目前不被认为是任何眼部疾病的一线治疗选择。Δ-9-tetrahydrocannabinol已被证明可以短期降低眼压,但没有足够的证据支持其用于治疗青光眼。大麻素的潜在治疗应用包括作为治疗难治性眼睑痉挛的二线药物,用于具有角膜抗炎特性的干眼病,以及用于抑制多发性硬化症患者的摆状眼球震颤,这些都需要进一步的临床实践研究。
{"title":"Adverse Ocular Impact and Emerging Therapeutic Potential of Cannabis and Cannabinoids: A Narrative Review.","authors":"Mostafa Bondok, Anne Xuan-Lan Nguyen, Leonardo Lando, Albert Y Wu","doi":"10.2147/OPTH.S501494","DOIUrl":"10.2147/OPTH.S501494","url":null,"abstract":"<p><p>Cannabis is the most used drug worldwide with an estimated 219 million users. This narrative review aims to explore the adverse effects and therapeutic applications of cannabis and cannabinoids on the eye, given its growing clinical and non-clinical uses. The current literature reports several adverse ocular effects of cannabis and cannabinoids, including eyelid tremor, ptosis, reduced corneal endothelial cell density, dry eyes, red eyes, and neuro-retinal dysfunction. Cannabinoids may transiently impair night vision, depth perception, binocular and monocular contrast sensitivity, and dynamic visual acuity. Cannabinoids are not currently considered a first-line treatment option for any ocular conditions. Δ-9-tetrahydrocannabinol been shown to result in short-term intraocular pressure reduction, but insufficient evidence to support its use in treating glaucoma exists. Potential therapeutic applications of cannabinoids include their use as a second-line agent for treatment-refractory blepharospasm, for dry eye disease given corneal anti-inflammatory properties, and for suppression of pendular nystagmus in individuals with multiple sclerosis, which all necessitate further research for informed clinical practices.</p>","PeriodicalId":93945,"journal":{"name":"Clinical ophthalmology (Auckland, N.Z.)","volume":"18 ","pages":"3529-3556"},"PeriodicalIF":0.0,"publicationDate":"2024-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11613704/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142775648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical ophthalmology (Auckland, N.Z.)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1